Illuminare Biotechnologies

New York, NY · Founded 2016 · Privately Held (backing)

Developer of an intra-operative nerve visualization technology intended to reduce the risk of nerve damage. Illuminare Biotechnologies is based in New York, NY and was founded in 2016. Its last reported valuation was $11.4 million in Aug 2017. It has raised $7.1 million across 1 recorded round; the latest was a $3.6 million seed round in May 2026.

Last reported valuation
$11.4M
Oct 2026
Priced at
—
Total raised
$7.1M
Last round
Seed Round
May 2026
What is Illuminare Biotechnologies worth?
$11.4Mlast reported valuation · Oct 2026

Illuminare Biotechnologies's last reported valuation, Aug 2017. Nothing priced has surfaced since.

Pro
The prices on Illuminare Biotechnologies
  • ·2 fund marks: filer, period, implied $/share
Pro · $99 a month
List $299 · founding price, locked for as long as you stay

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Illuminare Biotechnologies funding history

1 rounds
DateRoundRaisedPost-money
May 2026Seed Round$3.6M▮
Unlock post-money valuations

Membership and data by Private Market View

Illuminare Biotechnologies valuation

Illuminare Biotechnologies's last reported valuation was $11.4 million in Aug 2017. No priced round, secondary trade or fund mark has surfaced since.

How much has Illuminare Biotechnologies raised?

Illuminare Biotechnologies has raised $7.1 million in total; 1 of its rounds is on record. The largest on record was a $3.6 million seed round in May 2026.

Illuminare Biotechnologies has filed 1 Form D with the SEC, most recently in Dec 2018 (null sold).

Institutional holders and vehicles

1 SEC-registered fund reported 2 fair-value marks on Illuminare Biotechnologies between Dec 2025 and Mar 2026, in their N-PORT filings. Filer-level marks and implied per-share values are available to Pro members.

How Illuminare Biotechnologies's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Illuminare Biotechnologies, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about Illuminare Biotechnologies

What is Illuminare Biotechnologies worth?
Illuminare Biotechnologies is valued at $11.4M as of Oct 2026. Illuminare Biotechnologies's last reported valuation, Aug 2017. Nothing priced has surfaced since.
How much has Illuminare Biotechnologies raised?
Illuminare Biotechnologies has raised $7.1M in total funding across 1 recorded rounds.
When did Illuminare Biotechnologies last raise?
Illuminare Biotechnologies last raised in May 2026 (Seed Round), raising $3.6M.